• de
    • en
  • Viral Infections
    • COVID-19
      • Therapy Studies
        • APN01-COVID-19

          Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19

        • COMIHY

          Hydroxychloroquine for the treatment of mild COVID-19 disease

        • COVARI

          A clinical trial to assess the efficacy and safety of PB432 in COVID-19 positive inpatients with acute respiratory insufficiency (ARI)

        • COVID-19 ACTT-EU/UK

          A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults – Version for European Union/United Kingdom Sites

        • COVID-19 EFC16844

          An adaptive phase 2/3, randomized, double-blind, placebocontrolled study assessing efficacy and safety of sarilumab for hospitalized patients with COVID19

        • COVID-19 Hydroxychloroquine for COVID-19

          Randomized controlled trial of hydroxychloroquine versus placebo for the treatment of adult patients with acute coronavirus disease 2019 – COVID-19

        • COVID-19 XPORT-CoV-1001

          A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients with Severe Covid-19 Infection

        • CovidVal01

        • COVit

        • GI-HOPE

          GM-CSF Inhalation to improve HOst defense and Pulmonary barrier rEstoration

        • GS-US-540-5773

          Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)

        • GS-US-540-5774

          A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment

        • RECOVER

          A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease

        • RuxoCoFlaM

          A Phase-II Clinical Trial for First Line Treatment of Stage II/III Covid-19 Patients to Treat Hyperinflammation

        • RUXOCOIL

          A single-arm, open-label, phase II study of ruxolitinib in Covid-19 patients at risk of developing acute respiratory distress syndrome

        • WHO-SOLIDARITY-GERMANY

          An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care - WHO-SOLIDARITY-GERMANY

      • Impfstudien
      • Prophylaxis Studies
      • Antibody Studies
      • Compassionate Use Programme
        • COVID-19 Remdesivir Compassionate Use

          Remdesivir compassionate use program

      • Diagnostic Studies
        • Antigen POC Tests COVID-19

          Evaluation of the performance of novel rapid diagnostics for SARS-CoV-2 at point-of-care

      • Non-interventional Studies, Biobanking, Registries
        • Aspergillosis in COVID19 on ICU

          Pulmonary Aspergillosis in Critically Ill COVID19 Patients in Intensive Care Unit - a Multinational Explorative Trial

        • CoPa

        • Corona und Kognition

        • CORSAAR

        • COVID-19 Case-Cluster-Study-Heinsbergstudie

        • COVID-19 LEOSS Register

          Lean European Open Survey on SARS-CoV-2

        • COVID-19 Mobile Tests für Köln - Community

          COVID-19 Mobile Tests für Köln - Community

        • COVID-19 Mobile Tests für Köln - Uniklinik

          COVID-19 Mobile Tests for Cologne

        • GPN Register für COVID-19

        • ISI - Improving Diagnosis of Severe Infections in Immunocompromised Patients

          Improving Diagnosis of Severe Infections in Immunocompromised Patients (ISI)

        • Kidney in COVID-19

          Kidney in Coronavirus Disease 2019 Registry

        • Pa-COVID-19

          Phenotyping platform and logitudinal register for COVID-19 patients at Charité

        • ProCoV

        • PROTEGO

          Evaluation of the course of COVID-19 disease and perceptions among those tested positive – a prospective and retrospective survey based study

        • PROVID-CAPSyS

        • PROVID-PROGRESS

        • Telemed500-Covid-19

      • Master Protocols
        • COVID-19 Clinical Trials Master Protocol

          A Multi-center, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients

      • SARS-CoV-2 Best Practice
      • COVARI

        A clinical trial to assess the efficacy and safety of PB432 in COVID-19 positive inpatients with acute respiratory insufficiency (ARI)

      • PROVID-CAPSyS

      • PROVID-PROGRESS

      • Telemed500-Covid-19

    • MERS-CoV
    • Ebola
    • Hepatitis
    • HIV / AIDS
    • Influenza
    • Varizella zoster
  • Bacterial Infections
  • Infektionen bei Immungeschwächten Patienten
  • Invasive Pilzinfektionen
  • Gastrointestinale Infektionen
© 2025 Healex GmbH Legal notice Privacy